Press release
Cell and Gene Therapy Bioassay Services Market | Size, Share and Scope Analysis to 2031
According to the latest research by InsightAce Analytic, the global cell and gene therapy bioassay services market is valued at US$ 1.84 Billion in 2022, and it is expected to reach US$ 5.64 Billion by 2031 with a CAGR of 15.3 % during a forecast period of 2023-2031.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1208
Cell and gene therapies include extracting protein, cells, or genetic material from the patient or donor and altering them to provide a highly targeted or personalized treatment. These therapies can treat complex & rare diseases and provide long-lasting benefits than traditional treatments. Hence, the demand for various contract research organizations that offer bioassay services for cell and gene therapies has increased over the years.
Numerous factors such as the increasing need for advanced therapy treatments, rising incidence of cancer and other chronic diseases, advancements in genomics technology methods are predominantly driving the market growth. Increasing demand for personalized therapies and increasing government funding for the R&D of innovative cell & gene therapies are further anticipated to boost the demand for the bioassay services market during the forecast period. Due to the increasing demand for cost-effective and efficient cell & gene therapies, outsourcing contract research organizations (CROs) have expanded the bioassay services, thereby fueling market growth opportunities in the near future. Various contract research businesses claiming to provide bioassay services for cell and gene therapies have developed as the demand for outsourcing bioanalytical services grows. However, the high cost of bioassay services may restrict the growth of the global cell and gene therapy bioassay services market in the upcoming years.
Geographically, North America is estimated to hold the maximum share of the market over the forecast years due to the increasing launch of cell and gene therapy products and increasing R&D activities in biopharma companies to develop cell and gene therapies.
Request for ToC: https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-bioassay-services-market/1208
Major market players operating in the cell and gene therapy bioassay services market include AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Lonza (Switzerland), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Pacific BioLabs (US), WuXi Advanced Therapies (US), Porton Biopharma Ltd (UK), Avomeen (US), Charles River Laboratories (US), BioAgilytix Labs (US), Absorption Systems (US), Catalent, Inc (US), Svar Life Science AB (Sweden) among others.
Some significant developments in the market:
In Dec 2021, Mediphage Bioceuticals, Inc. has been acquired by CCRM Enterprises Inc., the company's venture capital arm. CCRM Enterprises' investment will be used to fund the technology's development and continued operations, as well as access to CCRM's scientific and industrial experience. Mediphage is focusing on a non-viral gene therapy platform that will pave the way for personalized genetic treatment that is both safe and effective, while also addressing many of the drawbacks of current viral vector-based gene therapy technologies.
In April 2021, AavantiBio (US), a gene therapy company, and Catalent (US), the provider of drugs, cell & gene therapies, partnered to support the development and manufacturing of AavantiBio's gene therapies.
In November 2021, WuXi Advanced Therapies (US) opened a new cell and gene therapy testing facility with 140,000 square feet of laboratory space. This facility will further enhance the company's contract testing, development, and manufacturing organization (CTDMO) business model by tripling the company's previous testing capacity, meeting the increasing needs of customers in the cell and gene therapy industry.
In April 2021, PPD, Inc., a global contract research organization ( CRO ), is expanding its Athlone, Ireland, GMP laboratory, increasing the size of its current facility and adding cell and gene therapy testing to the operation's portfolio of services.The expansion enhances PPD's ability to deliver global scientific and technical expertise to meet growing customer demand in Europe, the Middle East and Africa, and the Asia-Pacific region
In Jan 2021, Nexelis has signed an asset purchase agreement with GSK to acquire its GCLP-certified clinical bioanalytical laboratory located in Marburg, Germany.Nexelis intends to quickly expand the Marburg site, initiating collaborations with other vaccine development companies as well as with the company's other North American and European sites.
Obtain Full Report Details @ https://www.insightaceanalytic.com/request-sample/1208
Market Segments
Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Type of Therapy, 2023-2031 (Value US$ Mn)
Gene Therapy
Cell Therapy
Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Therapeutic Area, 2023-2031 (Value US$ Mn)
Oncological
Cardiovascular
Autoimmune
Rare / Genetic
Neurological
Metabolic
Blood
Ophthalmic Disorders
Infectious
Other Therapeutic Areas
Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Scale of Operation, 2023-2031 (Value US$ Mn)
Preclinical
Clinical
Discovery
Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Region, 2023-2031 (Value US$ Mn)
Europe
North America
Asia Pacific
Middle East & Africa
Latin America
North America Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2023-2031 (Value US$ Mn)
Canada
U.S.
Europe Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2023-2031 (Value US$ Mn)
Italy
Germany
Spain
France
Rest of Europe
Asia Pacific Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2023-2031 (Value US$ Mn)
India
Japan
South Korea
China
Australia & New Zealand
Latin America Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2023-2031 (Value US$ Mn)
Brazil
Mexico
Rest of Latin America
Middle East & Africa Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2023-2031 (Value US$ Mn)
South Africa
GCC Countries
Rest of Middle East & Africa
Why should buy this market research report:
To receive a key insights of the prospects for the global cell and gene therapy bioassay services market
To receive an market overview and future trends of the cell and gene therapy bioassay services market
To analyze the cell and gene therapy bioassay services market drivers and challenges
To get information on the cell and gene therapy bioassay services market size value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the cell and gene therapy bioassay services market industry
Get More Information @ https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-bioassay-services-market/1208
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: https://www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Follow Us @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell and Gene Therapy Bioassay Services Market | Size, Share and Scope Analysis to 2031 here
News-ID: 3079884 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd
Veterinary Infectious Disease Diagnostics Market Advancements Highlighted by Gro …
"Veterinary Infectious Disease Diagnostics Market" in terms of revenue was estimated to be worth $2.06 billion in 2023 and is poised to reach $3.95 billion by 2031, growing at a CAGR of 3.95% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1488
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the veterinary infectious disease diagnostics market are:
• Rising rates of zoonotic…
Manuka Honey Market Know the Scope and Trends Revealed In New Report
"Manuka Honey Market" in terms of revenue was estimated to be worth $483.31 Mn in 2023 and is poised to reach $729.63 Mn by 2031, growing at a CAGR of 5.43% from 2024 to 2031, according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1554
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Manuka Honey Market are:
· Health…
Geospatial Analytics Market Report Explores the Exclusive Report with Detailed S …
"Geospatial Analytics Market" in terms of revenue was estimated to be worth $74.83 billion in 2023 and is poised to reach $191.61 billion by 2031, growing at a CAGR of 12.72% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1641
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Geospatial Analytics Market are:
• Increasing Adoption of Location-Based Services (LBS)
• Growing Awareness of…
Alcoholic Energy Drinks Market Current Scenario with Future Aspect Analysis
"Alcoholic Energy Drinks Market" in terms of revenue was estimated to be worth $27.92 billion in 2023 and is poised to reach $49.20 billion by 2031, growing at a CAGR of 7.50% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1531
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Alcoholic Energy Drinks Market are:
• Increasing consumer demand for innovative beverage…
More Releases for Therapy
Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023.
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand…
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market.
Factors that are likely to hamper the growth of the market…
